Cargando…
Polycomponent mesotherapy formulations for the treatment of skin aging and improvement of skin quality
Skin aging can largely be attributed to dermal fibroblast dysfunction and a decrease in their biosynthetic activity. Regardless of the underlying causes, aging fibroblasts begin to produce elements of the extracellular matrix in amounts that are insufficient to maintain the youthful appearance of sk...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396578/ https://www.ncbi.nlm.nih.gov/pubmed/25897252 http://dx.doi.org/10.2147/CCID.S76721 |
_version_ | 1782366604789547008 |
---|---|
author | Prikhnenko, Sergey |
author_facet | Prikhnenko, Sergey |
author_sort | Prikhnenko, Sergey |
collection | PubMed |
description | Skin aging can largely be attributed to dermal fibroblast dysfunction and a decrease in their biosynthetic activity. Regardless of the underlying causes, aging fibroblasts begin to produce elements of the extracellular matrix in amounts that are insufficient to maintain the youthful appearance of skin. The goal of mesopreparations is primarily to slow down and correct changes in skin due to aging. The rationale for developing complex polycomponent mesopreparations is based on the principle that aging skin needs to be supplied with the various substrates that are key to the adequate functioning of the fibroblast. The quintessential example of a polycomponent formulation – NCTF(®) (New Cellular Treatment Factor) – includes vitamins, minerals, amino acids, nucleotides, coenzymes and antioxidants, as well as hyaluronic acid, designed to help fibroblasts function more efficiently by providing a more optimal environment for biochemical processes and energy generation, as well as resisting the effects of oxidative stress. In vitro experiments suggest that there is a significant increase in the synthetic and prophylactic activity of fibroblasts with treated NCTF, and a significant increase in the ability of cells to resist oxidative stress. The current article looks at the rationale behind the development of polycomponent mesopreparations, using NCTF as an example. |
format | Online Article Text |
id | pubmed-4396578 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-43965782015-04-20 Polycomponent mesotherapy formulations for the treatment of skin aging and improvement of skin quality Prikhnenko, Sergey Clin Cosmet Investig Dermatol Expert Opinion Skin aging can largely be attributed to dermal fibroblast dysfunction and a decrease in their biosynthetic activity. Regardless of the underlying causes, aging fibroblasts begin to produce elements of the extracellular matrix in amounts that are insufficient to maintain the youthful appearance of skin. The goal of mesopreparations is primarily to slow down and correct changes in skin due to aging. The rationale for developing complex polycomponent mesopreparations is based on the principle that aging skin needs to be supplied with the various substrates that are key to the adequate functioning of the fibroblast. The quintessential example of a polycomponent formulation – NCTF(®) (New Cellular Treatment Factor) – includes vitamins, minerals, amino acids, nucleotides, coenzymes and antioxidants, as well as hyaluronic acid, designed to help fibroblasts function more efficiently by providing a more optimal environment for biochemical processes and energy generation, as well as resisting the effects of oxidative stress. In vitro experiments suggest that there is a significant increase in the synthetic and prophylactic activity of fibroblasts with treated NCTF, and a significant increase in the ability of cells to resist oxidative stress. The current article looks at the rationale behind the development of polycomponent mesopreparations, using NCTF as an example. Dove Medical Press 2015-04-07 /pmc/articles/PMC4396578/ /pubmed/25897252 http://dx.doi.org/10.2147/CCID.S76721 Text en © 2015 Prikhnenko. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Expert Opinion Prikhnenko, Sergey Polycomponent mesotherapy formulations for the treatment of skin aging and improvement of skin quality |
title | Polycomponent mesotherapy formulations for the treatment of skin aging and improvement of skin quality |
title_full | Polycomponent mesotherapy formulations for the treatment of skin aging and improvement of skin quality |
title_fullStr | Polycomponent mesotherapy formulations for the treatment of skin aging and improvement of skin quality |
title_full_unstemmed | Polycomponent mesotherapy formulations for the treatment of skin aging and improvement of skin quality |
title_short | Polycomponent mesotherapy formulations for the treatment of skin aging and improvement of skin quality |
title_sort | polycomponent mesotherapy formulations for the treatment of skin aging and improvement of skin quality |
topic | Expert Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396578/ https://www.ncbi.nlm.nih.gov/pubmed/25897252 http://dx.doi.org/10.2147/CCID.S76721 |
work_keys_str_mv | AT prikhnenkosergey polycomponentmesotherapyformulationsforthetreatmentofskinagingandimprovementofskinquality |